Doximity CEO Says AI Is Unlocking a Bigger Market Than Expected, Shares Surge 34%
DOCS sits 70% above its 52-week low of $17.15 on elevated volume (11× avg).
Summary
Doximity's CEO said AI is opening a larger commercial opportunity than anticipated, with AI products now used by 165 health system clients and driving record engagement. The comments came after fiscal Q1 results beat revenue expectations and full-year guidance was raised, but the real story is the AI traction: workflow active prescriber growth exceeded 30% year over year, AI Search queries jumped 25% sequentially, and the Doximity Ask clinical assistant posted a 4.8% error rate versus 13.6% for Anthropic's leading model. The stock surged 34% on Friday, likely amplified by a short squeeze with over 16% of the float sold short. This follows yesterday's earnings release and guidance raise, but the CEO's AI commentary and specific product metrics are new and signal a potentially larger addressable market. The annual meeting on August 27 may provide further strategic updates.
At the time of this announcement, DOCS was trading at $29.10 on NYSE in the Technology sector, with a market capitalization of approximately $5.2B. The 52-week trading range was $17.15 to $76.51. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Benzinga.